CIK 0001855175
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Contineum Therapeutics, Inc.
Sign in to watch- Ticker
- CTNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271467257
- Phone
- +1 858-333-5280
- Business address
- 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
- 4 Planned sale Chief Scientific Officer sold 8,124 shares at an average $16.02 ($130,164)
- 4 Planned sale Chief Scientific Officer sold 100 shares at $16.00 ($1,600)
- 4 Planned sale CEO and President sold 400 shares at $16.00 ($6,400)
- 4 Planned sale Chief Scientific Officer sold 400 shares at $16.00 ($6,400)
- 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $14.94 ($62,305)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CMO & Head of Development sold 3,611 shares at an average $14.18 ($51,188)
- 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $10.44 ($43,543)
- 4 Planned sale CMO & Head of Development sold 3,611 shares at $12.06 ($43,558)
- 4 Planned sale Chief Scientific Officer sold 4,170 shares at $12.23 ($51,009)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 4 · 78 filings